Xiaoping Yang

Qingdao, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Antibody-based targeted protein degradation: Mechanisms, challenges and future directions.

Antibody-based targeted protein degradation: Mechanisms, challenges and future directions.

Journal: International journal of biological macromolecules

Published: September 24, 2025

Nano-PROTACs for precision medicine: engineering strategies for enhanced targeting and potency.

Nano-PROTACs for precision medicine: engineering strategies for enhanced targeting and potency.

Journal: Journal of nanobiotechnology

Published: September 18, 2025

STING-targeting PROTACs: emerging therapeutic tools for enhanced immunotherapy in inflammatory diseases.

STING-targeting PROTACs: emerging therapeutic tools for enhanced immunotherapy in inflammatory diseases.

Journal: Frontiers in immunology

Published: May 28, 2025

Anti-MDA5 antibody positive dermatomyositis complicated by interstitial lung disease with an improved outcome: A case report.

Anti-MDA5 antibody positive dermatomyositis complicated by interstitial lung disease with an improved outcome: A case report.

Journal: Medicine

Published: May 26, 2025

Application of Pharmaceutical Nanotechnologies for Chinese Herbal Medicines in the Treatment of Pulmonary Diseases and Lung Cancer.

Application of Pharmaceutical Nanotechnologies for Chinese Herbal Medicines in the Treatment of Pulmonary Diseases and Lung Cancer.

Journal: International journal of nanomedicine

Published: May 21, 2025

Self-enhancing targeted nanoparticles mediating M6PR up-regulation on tumor cell membranes to promote Granzyme B internalization for sensitizing tumor immunotherapy.

Self-enhancing targeted nanoparticles mediating M6PR up-regulation on tumor cell membranes to promote Granzyme B internalization for sensitizing tumor immunotherapy.

Journal: Journal of colloid and interface science

Published: May 11, 2025

Identification of SUMOylation modifiers involved in lung adenocarcinoma progression and Osimertinib resistance by integrated bioinformatics analysis.

Identification of SUMOylation modifiers involved in lung adenocarcinoma progression and Osimertinib resistance by integrated bioinformatics analysis.

Journal: Scientific reports

Published: December 10, 2024

A Case of Advanced Lung Adenocarcinoma Successfully Treated by Intratumoral Injection of Tirelizumab Under Tracheoscopy.

A Case of Advanced Lung Adenocarcinoma Successfully Treated by Intratumoral Injection of Tirelizumab Under Tracheoscopy.

Journal: Cancer reports (Hoboken, N.J.)

Published: November 09, 2024

Instantaneous Self-Healing Chitosan Hydrogels with Enhanced Drug Leakage Resistance for Infected Stretchable Wounds Healing.

Instantaneous Self-Healing Chitosan Hydrogels with Enhanced Drug Leakage Resistance for Infected Stretchable Wounds Healing.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: October 17, 2024

Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.

Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.

Journal: Frontiers in oncology

Published: October 09, 2024

Host-dependent C-to-U RNA editing in SARS-CoV-2 creates novel viral genes with optimized expressibility.

Host-dependent C-to-U RNA editing in SARS-CoV-2 creates novel viral genes with optimized expressibility.

Journal: Frontiers in cellular and infection microbiology

Published: August 06, 2024

C-to-U RNA deamination is the driving force accelerating SARS-CoV-2 evolution.

C-to-U RNA deamination is the driving force accelerating SARS-CoV-2 evolution.

Journal: Life science alliance

Published: August 23, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026